Beth G. Scherer

1.3k total citations
11 papers, 1.0k citations indexed

About

Beth G. Scherer is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Beth G. Scherer has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Infectious Diseases. Recurrent topics in Beth G. Scherer's work include Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Beth G. Scherer is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Beth G. Scherer collaborates with scholars based in United States and Germany. Beth G. Scherer's co-authors include Horst Zincke, David G. Bostwick, Michael L. Blute, Erik J. Bergstralh, Liang Cheng, Roxann M. Neumann, Amy L. Weaver, Bradley C. Leibovich, Liang Cheng and Ajay Nehra and has published in prestigious journals such as Cancer, The Journal of Urology and American Journal of Clinical Pathology.

In The Last Decade

Beth G. Scherer

11 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth G. Scherer United States 9 597 491 226 213 119 11 1.0k
Iori Sakai Japan 18 509 0.9× 239 0.5× 128 0.6× 88 0.4× 137 1.2× 48 708
Ataru Sazawa Japan 18 246 0.4× 549 1.1× 39 0.2× 192 0.9× 156 1.3× 47 831
Justine Varinot France 14 175 0.3× 388 0.8× 49 0.2× 121 0.6× 112 0.9× 39 619
Kristin M. Sanderson United States 11 178 0.3× 416 0.8× 89 0.4× 232 1.1× 290 2.4× 14 857
Takafumi Yanagisawa Japan 16 557 0.9× 448 0.9× 53 0.2× 122 0.6× 247 2.1× 152 951
W.F. Whitmore United States 8 592 1.0× 249 0.5× 163 0.7× 35 0.2× 87 0.7× 12 839
Sudhir Rawal India 14 364 0.6× 238 0.5× 135 0.6× 75 0.4× 132 1.1× 84 693
William J. Terry United States 8 714 1.2× 184 0.4× 309 1.4× 118 0.6× 114 1.0× 11 830
Jae Young Joung South Korea 16 589 1.0× 287 0.6× 23 0.1× 83 0.4× 355 3.0× 83 929
Martin Friedrich Germany 12 127 0.2× 441 0.9× 19 0.1× 113 0.5× 244 2.1× 17 758

Countries citing papers authored by Beth G. Scherer

Since Specialization
Citations

This map shows the geographic impact of Beth G. Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth G. Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth G. Scherer more than expected).

Fields of papers citing papers by Beth G. Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth G. Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth G. Scherer. The network helps show where Beth G. Scherer may publish in the future.

Co-authorship network of co-authors of Beth G. Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Beth G. Scherer. A scholar is included among the top collaborators of Beth G. Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth G. Scherer. Beth G. Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cheng, Liang, Horst Zincke, Michael L. Blute, et al.. (2001). Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 91(1). 66–73. 284 indexed citations
2.
Blute, Michael L., et al.. (2001). USE OF GLEASON SCORE, PROSTATE SPECIFIC ANTIGEN, SEMINAL VESICLE AND MARGIN STATUS TO PREDICT BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 165(1). 119–125. 233 indexed citations
3.
Cheng, Liang, Amy L. Weaver, Bradley C. Leibovich, et al.. (2000). Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 88(10). 2326–2332. 113 indexed citations
4.
Cheng, Liang, Roxann M. Neumann, Amy L. Weaver, et al.. (2000). Grading and Staging of Bladder Carcinoma in Transurethral Resection Specimens. American Journal of Clinical Pathology. 113(2). 275–279. 107 indexed citations
5.
Cheng, Liang, Bradley C. Leibovich, Erik J. Bergstralh, et al.. (1999). p53 Alteration in regional lymph node metastases from prostate carcinoma. Cancer. 85(11). 2455–2459. 36 indexed citations
6.
Cheng, Liang, Amy L. Weaver, Roxann M. Neumann, Beth G. Scherer, & David G. Bostwick. (1999). Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. Cancer. 86(6). 1035–1043. 88 indexed citations
7.
Cheng, Liang, Roxann M. Neumann, Beth G. Scherer, et al.. (1999). Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma. Cancer. 85(12). 2638–2647. 73 indexed citations
8.
Cheng, Liang, Thomas M. Pisansky, Thomas J. Sebo, et al.. (1999). Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression.. PubMed. 5(10). 2820–3. 43 indexed citations
9.
Cheng, Liang, Thomas J. Sebo, Bradley C. Leibovich, et al.. (1999). CELL PROLIFERATION IN PROSTATE CANCER PATIENTS WITH LYMPH NODE METASTASIS. The Journal of Urology. 175–175. 1 indexed citations
10.
Cheng, Liang, Erik J. Bergstralh, Beth G. Scherer, et al.. (1999). Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer. 85(6). 1300–1304. 32 indexed citations
11.
Schedel, H., et al.. (1991). Diagnostik akuter Myositiden. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 155(10). 370–372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026